BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31722693)

  • 1. Integrative molecular analysis of metastatic hepatocellular carcinoma.
    Wang D; Zhu Y; Tang J; Lian Q; Luo G; Wen W; Zhang MQ; Wang H; Chen L; Gu J
    BMC Med Genomics; 2019 Nov; 12(1):164. PubMed ID: 31722693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma.
    Lin T; Lin Z; Mai P; Zhang E; Peng L
    Aging (Albany NY); 2021 Apr; 13(8):11786-11807. PubMed ID: 33878734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrently deregulated lncRNAs in hepatocellular carcinoma.
    Yang Y; Chen L; Gu J; Zhang H; Yuan J; Lian Q; Lv G; Wang S; Wu Y; Yang YT; Wang D; Liu Y; Tang J; Luo G; Li Y; Hu L; Sun X; Wang D; Guo M; Xi Q; Xi J; Wang H; Zhang MQ; Lu ZJ
    Nat Commun; 2017 Feb; 8():14421. PubMed ID: 28194035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative transcriptome analysis reveals that the extracellular matrix receptor interaction contributes to the venous metastases of hepatocellular carcinoma.
    Zhang H; Ye J; Weng X; Liu F; He L; Zhou D; Liu Y
    Cancer Genet; 2015 Oct; 208(10):482-91. PubMed ID: 26271415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma.
    Liu S; Guo W; Shi J; Li N; Yu X; Xue J; Fu X; Chu K; Lu C; Zhao J; Xie D; Wu M; Cheng S; Liu S
    J Hepatol; 2012 Feb; 56(2):389-96. PubMed ID: 21888875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenome-wide DNA methylation profiling of portal vein tumor thrombosis (PVTT) tissues in hepatocellular carcinoma patients.
    Fan X; Li Y; Yi X; Chen G; Jin S; Dai Y; Cui B; Dai B; Lin H; Zhou D
    Neoplasia; 2020 Nov; 22(11):630-643. PubMed ID: 33059309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress on the molecular mechanism of portal vein tumor thrombosis formation in hepatocellular carcinoma.
    Zhang M; Ding Q; Bian C; Su J; Xin Y; Jiang X
    Exp Cell Res; 2023 May; 426(1):113563. PubMed ID: 36944406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma.
    Wang T; Hu HS; Feng YX; Shi J; Li N; Guo WX; Xue J; Xie D; Liu SR; Wu MC; Cheng SQ
    Br J Cancer; 2010 May; 102(11):1618-26. PubMed ID: 20461085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma.
    Zhuang L; Xu L; Wang P; Meng Z
    PLoS One; 2015; 10(2):e0117274. PubMed ID: 25642945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
    Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
    Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Evaluation of Radiotherapy with Contrast-Enhanced Ultrasound in Non-Resectable Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis.
    Li H; Liu J; Chen M; Li H; Long L
    Med Sci Monit; 2018 Nov; 24():8183-8189. PubMed ID: 30426970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification.
    Xu JF; Liu XY; Wang S; Wen HX
    World J Surg Oncol; 2015 Feb; 13():86. PubMed ID: 25889711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
    Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of sphingosine kinase 1 on the prognosis of hepatocellular carcinoma patients with portal vein tumor thrombus.
    Shi J; He YY; Sun JX; Guo WX; Li N; Xue J; Cheng SQ
    Ann Hepatol; 2015; 14(2):198-206. PubMed ID: 25671829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of microvascular invasion, portal vein tumor thrombosis and poor post-resectional survival in HBV-related hepatocellular carcinoma.
    Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
    Hepatogastroenterology; 2014 Sep; 61(134):1696-703. PubMed ID: 25436365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of two portal vein tumor thrombosis associated proteins in hepatocellular carcinoma: protein disulfide-isomerase A6 and apolipoprotein A-I.
    Xu X; Wei X; Ling Q; Cheng J; Zhou B; Xie H; Zhou L; Zheng S
    J Gastroenterol Hepatol; 2011 Dec; 26(12):1787-94. PubMed ID: 21649721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance and therapeutic potential of angiopoietin-like protein 4 in hepatocellular carcinoma.
    Ng KT; Xu A; Cheng Q; Guo DY; Lim ZX; Sun CK; Fung JH; Poon RT; Fan ST; Lo CM; Man K
    Mol Cancer; 2014 Aug; 13():196. PubMed ID: 25148701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.